Investors are responding to recent earnings reports and the positive momentum of the Chinese stock market.
Despite a downturn in the overall market, several Chinese stocks saw an increase today following the recent release of their financial reports. As of 12:37 PM EST, the stock price of the large Chinese e-commerce company Alibaba (BABA 7.80%) rose by almost 8%. The stock price of Chinese e-cigarette company RLX Technology (RLX 20.14%) skyrocketed by over 20%, while Lufax Holding Ltd (LX 17.20%) saw a rise in stock price by over 17%.
After a brutal year for the industry, the Chinese stock market has been gaining momentum recently. Earlier this week, Beijing released a 16-point plan to help the struggling real estate sector. The Chinese government also hopes to ease some of the restrictive pandemic policies that have indeed hampered economic growth this year. China's leaders also appear to have had a productive meeting with President Joe Biden.
Alibaba recently reported an adjusted diluted earnings per share of $1.82 for its American depositary shares, with a total revenue of $29.1 billion for the quarter. While the adjusted earnings exceeded analysts' expectations, the revenue performance was poor, with only a 3% year-over-year growth.
Alibaba CEO, Zhang Yong, stated in the company's financial report that "the uncertainty of the global situation will only strengthen our determination to focus on building capability, which will bring sustainable, high-quality, long-term growth for our customers and our own business.
The Alibaba Cloud division, which has been closely monitored by management, experienced a 4% year-on-year increase in revenue this quarter. However, internal sales of Chinese e-commerce decreased by 1% compared to the previous year, while international e-commerce sales increased by 4%.
Yesterday, RLX announced a profit of $71 million, a decrease of 48% compared to the previous year. Net income also significantly declined to $146.8 million, as the company stopped production of several products due to new regulations. RLX is also preparing to respond to a new 36% tax on the production or import of electronic cigarettes, which may temporarily harm their profitability.
Lufax Financial Technology has reported a diluted earnings per American Depositary Share of $0.21 for the quarter, which marks a nearly 48% decrease year-over-year. The company's total operating revenue for the quarter was $378.2 million, a decline of approximately 9.4% year-over-year. Lufax also reported a growth in its registered user base with a total of 184 million users, which marks an increase of over 19% year-over-year, and a loan issuance growth of more than 31% year-over-year for the quarter. Lufax is a consumer finance technology company.
It can be confidently said that none of these quarterly reports are particularly noteworthy. Alibaba's growth is minimal, Yueke is dealing with a series of new regulations, and although customer and source numbers are increasing, LexinFintech's earnings have significantly declined year-over-year.
However, due to China's wider economic struggles and particularly the impact of its COVID-19 prevention measures, this outcome was largely anticipated. The country's stock market has also suffered heavy losses this year, but investors seem to believe that it may have hit its lowest point amid all the positive signs.
Despite its growth slowing down, I still like Alibaba and I believe that things will improve under better economic conditions. However, due to all these new regulations, I am not very interested in RLX or LexinFintech, even though the market potential is huge, because of the uncertainty around how Chinese consumers will be able to support it from a credit perspective.
Statement:
This article is a compilation of third-party information, intended for communication and learning within the industry.
This article does not represent the viewpoint of 2FIRSTS and we cannot confirm the truthfulness or accuracy of its content. The translation of this article is solely meant for industry communication and research purposes.
Due to limitations in translation abilities, the translated article may not completely reflect the original text. Therefore, please refer to the original text for accuracy.
2FIRSTS is fully aligned with the Chinese government regarding its stance and statements concerning domestic, Hong Kong, Macau, Taiwan, and foreign issues.
The copyright of compiled information belongs to the original media and author. Please contact us for removal if there is any infringement.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
